ニューヨークにおける乳がんの臨床試験
ニューヨーク内の拠点で、乳がんに関する174件の研究が参加者を募集しています。
ニューヨーク内の都市
- New York City134件の研究
- Queens63件の研究
- Greenburgh42件の研究
- Staten Island40件の研究
- New Rochelle38件の研究
- The Bronx17件の研究
- Buffalo16件の研究
- Rochester15件の研究
- Brooklyn11件の研究
- Yonkers6件の研究
- Queensbury5件の研究
- Syracuse5件の研究
- Albany4件の研究
- Manhattan4件の研究
- Shirley3件の研究
公式研究テキスト（英語）
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
- Roswell Park Cancer Institute, Buffalo
被験者募集中健康なボランティア歓迎
18歳以上 · 女性 · 2026/10/02更新 · NCT03897270The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Queens Cancer Center of Queens Hospital, Jamaica
- Optum Health, Lake Success
- Mount Sinai School of Medicine, New York
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/10/02更新 · NCT05827081A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05534438A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Research Site, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07205822Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute IDS, Buffalo
- Memorial Sloan Kettering Hospital, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07701941A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Hematology Oncology Associates of Central New York, Camillus
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07102381Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Kings County Hopsital Center, Brooklyn
- Queens Cancer Center of Queens Hospital, Jamaica
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/10/01更新 · NCT04751435A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- University of Rochester Medical Center, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06369285Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
- Roswell Park Comprehensive Cancer Center, Buffalo
被験者募集中第2相
70歳以上 · 全性別 · 2026/10/01更新 · NCT04305834Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Memorial Sloan-Kettering Cancer Center, New York
- New York Cancer & Blood Specialists, Shirley
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
- Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/09/30更新 · NCT07218250Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
- New York Proton Center, New York
被験者募集中第3相
19歳以上 · 女性 · 2026/09/29更新 · NCT05856773A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- New York Proton Center, New York
被験者募集中第2相
50歳以上 · 女性 · 2026/09/29更新 · NCT01766297Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Mineola
- Avenzo Therapeutics Recruiting Site, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05867251A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Queens Hospital Cancer Center ( Site 0011), Jamaica
- Optum Medical Care, PC ( Site 0009), Westbury
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07060807A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- NYU Langone Health - Brooklyn ( Site 0089), Brooklyn
- NYU Langone Hospital - Long Island ( Site 0090), Mineola
- Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06312176A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, New York
- Research Site, Stony Brook
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06103864ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07007559A Study of Language Interpretation Solutions for People With Breast Cancer
- Memorial Sloan Kettering Suffolk- Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities), New York
- 他2件
被験者募集中
18歳以上 · 全性別 · 2026/09/25更新 · NCT06721065A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中第1相
18歳以上 · 女性 · 2026/09/24更新 · NCT05412225Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, New York
- Clinical Trial Site, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07085767Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- New York Cancer and Blood Specialists, Babylon
- NYU Langone Health, New York
- University of Rochester (URMC), Rochester
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/09/23更新 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- NYOH Albany Cancer Center, Albany
- New York University (NYU) Brooklyn, Brooklyn
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- Memorial Sloan Kettering Cancer Center, New York
- Wilmot Cancer Institute, Rochester
- New York Cancer and Blood Specialists, Shirley
被験者募集中第2相
18歳以上 · 女性 · 2026/09/22更新 · NCT07287098Intra-Operative Radiation Registry
- Montefiore Medical Center - Moses Campus, The Bronx
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/22更新 · NCT04994067A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- Weill Cornell Medicine, New York
被験者募集中健康なボランティア歓迎
30歳〜74歳 · 女性 · 2026/09/21更新 · NCT02620852Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中第2相
45歳以上 · 女性 · 2026/09/21更新 · NCT04084730ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Paradigm New York Cancer and Blood Specialists, Bay Shore
- Paradigm New York Cancer and Blood Specialists, New York
- Paradigm New York Cancer and Blood Specialists, New York
- 他9件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07173751A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Memorial Sloan Kettering Cancer Center Westchester, Harrison
- Beth Israel Comprehensive Cancer Center, New York
- Mount Sinai Medical Center, New York
- 他5件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06827236A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/16更新 · NCT06780176A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Kings County Hospital Center, Brooklyn
- Hematology Oncology Associates of Central New York, PC, East Syracuse
- Cayuga Medical Center, Ithaca
- 他9件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06246968A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Commack
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT05123482ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。